Navigation Links
Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results
Date:9/28/2007

LAVAL, QC, Sept. 28 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. (NASDAQ.NEPT - TSX.V.NTB), is pleased to report its financial results for the fiscal year ended May 31, 2007. During the last fiscal year, Neptune improved its productivity and operational profitability while continuing its business development strategy to penetrate the American, European and Asian markets, resulting in sustainable sales growth.

Financial Results and Highlights:

- Sales increased by 18% to $8,126,000 from $6,912,000 in the preceding

fiscal year.

- EBITDA increased by 43% to $1,504,000 from $1,049,000 in the preceding

fiscal year, representing a third consecutive year with a positive

EBITDA.

- EBITDA margin reached 18.5%, compared to 15.2% in the preceding fiscal

year.

- Excluding stock-based compensation expenses, Neptune would have

realized earnings of $152,000 instead of a loss of $2,677,000 in the

fiscal year ended May 31, 2007. Excluding stock-based compensation

expenses and an extraordinary gain from the settlement of debentures,

Neptune would have realized a loss of $1,574,000 instead of a loss of

$886,000 in the fiscal year ended May 31, 2006.

"We believe that the evaluation model and accounting method for stock-based compensation expenses are not appropriate for small capitalization fast growing companies. They do not bring the accounting value of stock-based compensation closer to the market value, as they should and as they were implemented for", stated Xavier Harland, Director of Finance.

"Neptune has managed to increase its EBITDA by $455,000 with a $1.2M increase in sales, confirming its improvement in operational efficiency", stated Andre Godin, Vice-President, Administration and Finance.

Neptune continues to strongly support its strategic development plan to pursue partnerships/strategic alliances with worldwide leaders in
'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...Mass., Dec. 1 Harvest Technologies...ults from the company sponsored 60-patient clinica...r in Chennai, India using the company,s BMAC Syste...cal Limb Ischemia (CLI). Sri Ramachandra Medical C...d institution based in Chennai, India and one of t...
(Date:12/1/2009)...IELD, Ill., Dec. 1 Prairie Heart I...that it was recently awarded two statuettes at the...3 in New York City. The CLIO Healthcare Awards rec...healthcare advertising industry and is an extensio...gnized awards competitions for advertising, design...
(Date:12/1/2009)...N.J., Dec. 1 Palatin Tec... that the U.S. Patent and Trademark Office has iss...iuretic Peptide Constructs." The claims in the is...t bind to natriuretic peptide receptor A (NPRA), i...g candidate. ,, "Our natriuretic compounds, inc...
(Date:12/1/2009)...ISCO, Dec. 1 Medizone In...nced today that in tests involving its proprietary... "6 log" decontamination barriers, this time with ...idium difficile and Bacillis subtilis. These resul...ly potent sporicidal technology. "The implications...
Breaking Biology Technology:Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2
... Inverness Medical,Innovations, Inc. (Amex: IMA ... and health management services, announced that it...bunal. That decision, directed at,Inverness, Binax...nd,Portugal approximately $13.8 million, including...Inverness is reviewing the decision and will,evalu...
... Conference and Awards Celebration has show of ...TTSBURGH, July 25 With the life sciences position...g an advantage amidst global,competition requires ...SINESS 2008 Conference and Awards Celebration, Nov...dge., The inaugural event will draw some 100 scie...
... Discuss Company,s IPLEX(TM) Program in Myotonic ...MOND, Va., July 25 Insmed Inc. (Nasdaq:,INSM) a d...cals, today,announced that Geoffrey Allan, Ph.D., ...rug Discovery and Development of Innovative Therap...., Dr. Allan will be participating in the Orphan ...
Other Biology Technology:Arbitration Panel Issues Ruling in Distribution Dispute 2Conference to Turn Scientists of Color into PA-Based Entrepreneurs Set for November 2Conference to Turn Scientists of Color into PA-Based Entrepreneurs Set for November 3Insmed CEO to Present at Drug Discovery & Development Conference 2
(Date:11/30/2009)...J. - The inaugural Global Conference on Systems &..., in Washington, DC, focuses on the convergence of...itical importance to society. , The goal of ... activity around targeted complex systems, examine...pic includes Critical Infrastructure Systems, incl...
(Date:11/30/2009)...tacle to HIV research is the virus,s exquisite spe...tists, traditional tools, like the humble lab mous...am of researchers writing in BioMed Central,s open...s assault on this problem by creating a mouse that...nfected with HIV. , George Kassiotis, from the D...
(Date:11/30/2009)...a colorless and odorless radioactive gas that is p... is a product of uranium decay and is found in tra...nd groundwater as well as building materials, plan...tration is expressed as the amount of radiation th...s in a liter of air; thus the units are picocuries...
Breaking Biology News(10 mins):First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2A reductionist approach to HIV research 2Health Physics Society recommends considering action for indoor radon below current guidelines 2How RNA polymerase II gets the go ahead for gene transcription 10309 1How RNA polymerase II gets the go ahead for gene transcription 10309 2How RNA polymerase II gets the go ahead for gene transcription 10309 3Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia 59207 1Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia 59207 2Smart For Life 28TM 29 Makes Debut on BJs com 59203 1Smart For Life 28TM 29 Makes Debut on BJs com 59203 2Smart For Life 28TM 29 Makes Debut on BJs com 59203 3
...nched, tropical seas; some species are found at de...hroughout the world,s oceans. Some cold-water cora...mals, a diversity rivaling some better known tropi...ttom trawling ?a commercial fishing method in whic... the bottom ?to be the greatest threat to cold-wat...
...an Physiological Society sessions at Experimental ...rated "for the first time that mitochondria are ab...mitochondria may mechanically regulate nuclear fun...or over 10 years, reported that it recently "found...ious substances which increase mitochondrial size,...
...d, but is there real neurophysiology behind it and...ented in an American Physiological Society session... Linda University, reports that not only is there ...ticipation of the "mirthful laughter" involved in ...urprising and significant neuroendocrine/hormone e...
Other Biology News:Ocean acidification threatens cold-water coral ecosystems 2First direct mechanical communication of mitochondria, cardiomyocyte nucleus shown 2First direct mechanical communication of mitochondria, cardiomyocyte nucleus shown 3Just the expectation of a mirthful laughter experience boosts endorphins 27 percent, HGH 87 percent 2Just the expectation of a mirthful laughter experience boosts endorphins 27 percent, HGH 87 percent 3
Rabbit Anti-TAK1, phospho (Thr184 / Thr187) Monoclonal Antibody, Unconjugated, Clone 90C7 from Cell Signaling Technology
Rat Anti-Gamma delta T Lymphocytes Monoclonal Antibody, Unconjugated, Clone MAC320 from BD Biosciences Pharmingen
Rabbit Anti-Human FAK, phospho (Ser843) Antibody, Unconjugated from Upstate
Mouse Anti-DcR1 Monoclonal Antibody, Biotin Conjugated, Clone DJR3 from Abcam
Biology Products: